Literature DB >> 10990487

Differentiation of necrotic cell death with or without lysosomal activation: application of acute liver injury models induced by carbon tetrachloride (CCL4) and dimethylnitrosamine (DMN).

M Yasuda1, T Okabe, J Itoh, S Takekoshi, H Hasegawa, H Nagata, R Y Osamura, K Watanabe.   

Abstract

We investigated the relationship between DNA degradation and lysosome activity (loss of lysosomal integrity) in necrotic cell death induced by carbon tetrachloride (CCl4) and dimethylnitrosamine (DMN): coagulation necrosis and hemorrhagic necrosis, respectively. TdT-mediated dUTP-biotin nick end-labeling (TUNEL) and enzyme histochemistry for acid phosphatase were performed in both models and results were analyzed by light microscopy, electron microscopy, and confocal laser scanning microscopy (CLSM). In the CCl(4)-injected liver, TUNEL staining was closely associated with release of lysosomal enzymes into the cytoplasm, and intranuclear deposition of lysosomal enzymes took place at an early stage of subcellular damage. In the DMN-injected liver, TUNEL-positive nuclei tended to have well-preserved lysosomes and centrally localized TUNEL signals. It was assumed that acute hepatocellular damage in the CCl4-injected liver would be characterized by necrotic cell death with lysosome activation and that damage in the DMN-injected liver would be necrotic cell death without lysosome activation. In the DMN-injected liver, DNA degradation may be selectively induced in the nuclear center, in which heterochromatin (including inactive chromatin) is believed to be a target. We concluded that necrotic cell death, i.e., DNA degradation, would be at least divided into two types, with/without association with lysosome activation, represented by necrotic cell death in the CCl4-injected liver and that in the DMN-injected liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990487     DOI: 10.1177/002215540004801004

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  5 in total

1.  Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats.

Authors:  Dong-Chang Zhao; Jun-Xia Lei; Rui Chen; Wei-Hua Yu; Xiu-Ming Zhang; Shu-Nong Li; Peng Xiang
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

2.  A high molecular weight protein extract of Mastobranchus indicus (Mi-64) having antiarthritic activity in experimental animals.

Authors:  Mohammed Aftab Alam; Santosh Kumar Sarkar; Antony Gomes
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine.

Authors:  Ryoko Yumoto; Teruo Murakami; Mikihisa Takano
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

4.  Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway.

Authors:  Xiao-Ling Guo; Bo Liang; Xue-Wei Wang; Fu-Gang Fan; Jing Jin; Rui Lan; Jing-Hui Yang; Xiao-Chun Wang; Lei Jin; Qin Cao
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

5.  Caspase-3 mediates the pathogenic effect of Yersinia pestis YopM in liver of C57BL/6 mice and contributes to YopM's function in spleen.

Authors:  Zhan Ye; Amanda A Gorman; Annette M Uittenbogaard; Tanya Myers-Morales; Alan M Kaplan; Donald A Cohen; Susan C Straley
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.